Digoxin
- Strength
- .25 mg/mL
- Form
- Injection
- Class
- Cardiac Glycoside
ProPharma Distribution
LANOXIN
digoxin
Listed by Covis Pharma US, Inc
- Strength
- 250 ug/mL
- Form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Class
- Cardiac Glycoside
What it contains
- Digoxin 250 ug/mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Intramuscular, Intravenous |
| Drug class | Cardiac Glycoside |
| Approval route | NDA — original brand approval |
| NDC code | 70515-260 |
| FDA application | NDA009330 |
| RxNorm concept | 104208 |
| Marketed since | September 2017 |
Other products containing Digoxin
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Digoxin
- Strength
- 125 ug/1
- Form
- Tablet
- Class
- Cardiac Glycoside
Major Pharmaceuticals
Digoxin
- Strength
- 125 ug/1
- Form
- Tablet
- Class
- Cardiac Glycoside
Amneal Pharmaceuticals of New York LLC
Digoxin
- Strength
- 125 ug/1
- Form
- Tablet
- Class
- Cardiac Glycoside
Hikma Pharmaceuticals USA Inc.
Digoxin
- Strength
- .0625 mg/1
- Form
- Tablet
- Class
- Cardiac Glycoside
ANI Pharmaceuticals, Inc.
Digoxin
- Strength
- .25 mg/mL
- Form
- Injection
- Class
- Cardiac Glycoside
Hikma Pharmaceuticals USA Inc.
Digoxin
- Strength
- .25 mg/1
- Form
- Tablet
- Class
- Cardiac Glycoside
A-S Medication Solutions
Digoxin
- Strength
- .25 mg/1
- Form
- Tablet
- Class
- Cardiac Glycoside
REMEDYREPACK INC.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.